Optimization of novel lead compounds for the treatment of African trypanosomiasis using innovative medicinal chemistry and formulation.
Dynamics and mechanisms of paromomycin and miltefosine drug-resistance in the protozoan parasite Leishmania.
Identifying factors involved in miltefosine or amphotericin B treatment failure in visceral leishmaniasis.
Veterinary and human parasitology.
INFLA-MED - Fundamental research in the pathophysiological processes of inflammatory diseases.
Publication type
|
|
|
|
|